Question 570
At Keystone BioLabs, the biomedical ML engineering team maintains approved laboratory image and classification pipelines under requirements for secure data preparation and controlled experiments. The production acceptance reviewer checks a proposed fix for: A team's AWS CDK stack uses the same fixed resource names across development and production and fails when a second environment is deployed. Which observed result BEST demonstrates that the correction works?
Explanation
Correct Answer
Both environments deploy without name collisions and their resource tags and model endpoints remain separate. This is observable proof for correction of: A team's AWS CDK stack uses the same fixed resource names across development and production and fails when a second environment is deployed. The approved design change is: Parameterize account, Region and environment-specific identifiers and maintain isolated deployment stacks and resource references. The Keystone BioLabs acceptance test separates measured ML behavior from an unverified implementation claim.
Incorrect Answers
A peak traffic replay meets p95 latency and shows the critical model remains available without repeated cold-load stalls. This would verify a different operation: Measure cache behavior and choose suitable memory capacity or a dedicated deployment for the critical high-frequency model. That separate action addresses: A multi-model server has frequent model cold loads that exceed the acceptance latency target for its highest-traffic model. It cannot establish the required Keystone BioLabs correction for: A team's AWS CDK stack uses the same fixed resource names across development and production and fails when a second environment is deployed. The decisive acceptance check is instead: Both environments deploy without name collisions and their resource tags and model endpoints remain separate.
A deliberately failed transform reports its stage and blocks downstream deployment without losing prior successful artifacts. This would verify a different operation: Split the workflow into traceable SageMaker Pipelines or Step Functions stages with typed inputs, outputs and failure handling. That separate action addresses: A pipeline combines data transformation, training and evaluation in one opaque shell command, obscuring which stage failed. It cannot establish the required Keystone BioLabs correction for: A team's AWS CDK stack uses the same fixed resource names across development and production and fails when a second environment is deployed. The decisive acceptance check is instead: Both environments deploy without name collisions and their resource tags and model endpoints remain separate.
A test candidate with a critical slice regression is blocked despite acceptable aggregate F1 performance. This would verify a different operation: Include explicitly approved per-segment acceptance checks and fairness review in the conditional deployment gates. That separate action addresses: A quality gate evaluates only global F1 score while a new candidate violates the acceptable error limit for a protected segment. It cannot establish the required Keystone BioLabs correction for: A team's AWS CDK stack uses the same fixed resource names across development and production and fails when a second environment is deployed. The decisive acceptance check is instead: Both environments deploy without name collisions and their resource tags and model endpoints remain separate.